The significant and growing global prevalence of diabetes continues to challenge people
with diabetes (PwD), healthcare providers, and payers. While maintaining near-normal …

Advances in diabetes technologies have enabled the development of automated closed-
loop insulin delivery systems. Several hybrid closed-loop systems have been …

Diabetes technologies represent a paradigm shift in type 1 diabetes care. Continuous
subcutaneous insulin infusion (CSII) pumps and continuous glucose monitors (CGM) …

In order to reduce medical facility overload due to the rise of the elderly population, modern
lifestyle diseases, or pandemics, the medical industry is currently developing point-of-care …

OBJECTIVE To minimize hypoglycemia in subjects with type 1 diabetes by automated
glucagon delivery in a closed-loop insulin delivery system. RESEARCH DESIGN AND …

Pursuit of a closed-loop artificial pancreas that automatically controls the blood glucose of
individuals with type 1 diabetes has intensified during the past 6years. Here we discuss the …

This review is focused on the materials and methods used to fabricate closed‐loop systems
for type 1 diabetes therapy. Herein, we give a brief overview of current methods used for …

Current artificial pancreas (AP) systems are hybrid closed-loop systems that require manual
meal announcements to manage postprandial glucose control effectively. This poses a …

Type 1 diabetes mellitus is a chronic autoimmune disease that affects millions of people and
generates high healthcare costs due to frequent complications when inappropriately …

This paper presents a comprehensive survey about the fundamental components of the
artificial pancreas (AP) system including insulin administration and delivery, glucose …